IL17A and rheumatoid arthritis: Five potential mechanism pathways of compound Xuanju capsule-treated RA were analyzed and summarized, namely, the IL-17 signaling pathway, the TNF signaling pathway, the Th17 cell differentiation pathway, the Toll receptor signaling pathway and the RA pathway.